PATOU GARY

Track

Insider profile

Performance

Overall performance
2.1
Performance over holding periods
2.1
30 days 90 days 120 days
Average return -9% 8.2% 15.1%
Success rate 18% 68% 82%
Transactions
8 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
PATOU GARY's trades of Xenon Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-08 2026-06-05
PlS Planned sale
88,478 +20.8%
89.81
US$823,931 		88,478 +20.8% 89.81 US$823,931
2026-06-05 2026-06-05
PrS Proposed sale
49,486
227.07
US$515,521 		49,486 227.07 US$515,521
2026-06-05 2026-06-05
PrS Proposed sale
60,222
41.74
US$3,848,009 		60,222 41.74 US$3,848,009
2024-11-22 2024-11-22
PrS Proposed sale
4,891
41.08
US$200,932 		4,891 41.08 US$200,932
2024-11-22 2024-11-22
S Sale
2,040 -8.0%
41.05
US$83,742 		2,040 -8.0% 41.05 US$83,742
2024-11-22 2024-11-22
S Sale
2,851 -10.8%
41.11
US$117,205 		2,851 -10.8% 41.11 US$117,205
2023-12-14 2023-12-14
PrS Proposed sale
7,598
40.42
US$307,073 		7,598 40.42 US$307,073
2023-12-15 2023-12-13
S Sale
7,598 -60.8%
41.05
US$311,898 		7,598 -60.8% 41.05 US$311,898
2023-12-15 2023-12-13
S Sale
3,977 -14.4%
39.84
US$158,444 		3,977 -14.4% 39.84 US$158,444
2023-12-15 2023-12-13
S Sale
2,303 -8.9%
39.10
US$90,047 		2,303 -8.9% 39.10 US$90,047
2023-12-15 2023-12-13
S Sale
5,100 -17.8%
38.94
US$198,594 		5,100 -17.8% 38.94 US$198,594
2023-12-13 2023-12-13
PrS Proposed sale
11,380
39.90
US$454,062 		11,380 39.90 US$454,062
2022-11-28 2022-11-25
S Sale
1,937 -7.6%
34.79
US$67,390 		1,937 -7.6% 34.79 US$67,390
2022-11-28 2022-11-23
S Sale
2,057 -8.0%
34.33
US$70,610 		2,057 -8.0% 34.33 US$70,610